Pharmesis International Ltd. (SGX:BFK)
0.4350
-0.1450 (-25.00%)
At close: May 13, 2025, 5:00 PM SGT
Pharmesis International Revenue
In the year 2024, Pharmesis International had annual revenue of 67.65M CNY with 48.24% growth. Pharmesis International had revenue of 43.78M in the half year ending December 31, 2024, with 38.52% growth.
Revenue
67.65M CNY
Revenue Growth
+48.24%
P/S Ratio
1.45
Revenue / Employee
61.72K CNY
Employees
1,096
Market Cap
18.39M SGD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 67.65M | 22.01M | 48.24% |
Dec 31, 2023 | 45.64M | -4.73M | -9.40% |
Dec 31, 2022 | 50.37M | -2.40M | -4.55% |
Dec 31, 2021 | 52.77M | 5.66M | 12.01% |
Dec 31, 2020 | 47.11M | 9.91M | 26.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DBS Group Holdings | 21.83B |
Oversea-Chinese Banking Corporation | 13.78B |
Singapore Telecommunications | 14.13B |
United Overseas Bank | 13.37B |
Singapore Technologies Engineering | 11.28B |
Singapore Airlines | 19.35B |
Wilmar International | 91.96B |
Jardine Matheson Holdings | 48.83B |